Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.

MLA

Leonetti, Alessandro, et al. “Real-World Outcomes of Italian Patients with Advanced Non-Squamous Lung Cancer Treated with First-Line Pembrolizumab plus Platinum-Pemetrexed.” European Journal of Cancer, vol. 202, May 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejca.2024.114006.

APA

Leonetti, A., Perrone, F., Puntoni, M., Maglietta, G., Bordi, P., Bria, E., Vita, E., Gelsomino, F., De Giglio, A., Gelibter, A., Siringo, M., Mazzoni, F., Caliman, E., Genova, C., Bertolini, F., Guaitoli, G., Passiglia, F., Delcuratolo, M. D., Montrone, M., & Cerea, G. (2024). Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed. European Journal of Cancer, 202, N.PAG. https://doi.org/10.1016/j.ejca.2024.114006

Chicago

Leonetti, Alessandro, Fabiana Perrone, Matteo Puntoni, Giuseppe Maglietta, Paola Bordi, Emilio Bria, Emanuele Vita, et al. 2024. “Real-World Outcomes of Italian Patients with Advanced Non-Squamous Lung Cancer Treated with First-Line Pembrolizumab plus Platinum-Pemetrexed.” European Journal of Cancer 202 (May): N.PAG. doi:10.1016/j.ejca.2024.114006.